Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab

NCT03798691 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Herpes Zoster

Interventions

BIOLOGICAL: Shingrix

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]